Independent Multi-Cohort RNA-Seq Analysis Does Not Support Recurrent DNAJB1::PRKACA Fusion in Hepatoblastoma or Biliary Atresia. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83.

Palaz F, Yu X, Bruner J, Feely M, Cai G, Duarte S, Zarrinpar A

Open source

DOI
10.3390/cancers18162681
Published
2026 Aug 19
Container
Cancers
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18162681,
  title = {Independent Multi-Cohort RNA-Seq Analysis Does Not Support Recurrent DNAJB1::PRKACA Fusion in Hepatoblastoma or Biliary Atresia. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83.},
  author = {Palaz F and Yu X and Bruner J and Feely M and Cai G and Duarte S and Zarrinpar A},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18162681},
  url = {https://doi.org/10.3390/cancers18162681}
}

RIS

TY  - JOUR
TI  - Independent Multi-Cohort RNA-Seq Analysis Does Not Support Recurrent DNAJB1::PRKACA Fusion in Hepatoblastoma or Biliary Atresia. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83.
AU  - Palaz F
AU  - Yu X
AU  - Bruner J
AU  - Feely M
AU  - Cai G
AU  - Duarte S
AU  - Zarrinpar A
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18162681
UR  - https://doi.org/10.3390/cancers18162681
ER  - 

APA

F, P., X, Y., J, B., M, F., G, C., S, D., & A, Z. (2026). Independent Multi-Cohort RNA-Seq Analysis Does Not Support Recurrent DNAJB1::PRKACA Fusion in Hepatoblastoma or Biliary Atresia. Comment on Fleifil et al. DNAJB1-PKAc Kinase Is Expressed in Young Patients with Pediatric Liver Cancers and Enhances Carcinogenic Pathways. Cancers 2025, 17, 83.. Cancers. https://doi.org/10.3390/cancers18162681

Source records